Objectives: To investigate the in~uence of mesothelial ceil (MC) seeding on patency and neointimaI formation of small diameter ePTEE grafts in a canine model. Materials and Methods: MC were isolated from the omentum, cultured, seeded on fibronectin-coated ePTFE grafts (4 cm, 4 mm ID), and implanted in the carotid artery of five Beagle dogs. Each dog also received a non-seeded control graft. Patency was assessed by palpation immediately after implantation, and non-invasively by magnetic resonance angiography (MRA) after 1 week and just prior to sacrifice (4 weeks). IntimaI thickness was quanti~ed on histological sections by use of computer-aided morphometry. Results: All grafts were patent after implantation. After 1 week, MRA showed the loss of lumen diameter in two seeded grafts. After 4 weeks, two seeded grafts were occluded, one seeded graft was severely stenosed, and all others were without angiographic lumen reduction. Histology and morphometry confirmed that two seeded grafts were occluded, and demonstrated that the other three seeded grafts showed signi~cantty more intima formation (0.22-1.34 ram) than the control grafts (<0.08 mm; p<O.01). Conclusions: The MC seeding process decreases patency and increases neointimal formation of small diameter ePTFE grafts in dogs and does not seem to be useful for reduction of graft thrombogenicity.
Introduction
Prosthetic small diameter bypasses perform poorly when compared to autologous vein grafts. 1 The thrombogenicity of the prosthetic materials is one of the reasons that they have failed to live up to their expectations. An endothelial cell monolayer on the luminal surface may lower the thrombogenicity and improve long-term patency, since endothelial cells form a non-thrombogenic surface and play a primary role in the regulation of intravascular coagulation. 2 In man, prosthetic grafts never endothelialise spontaneously, except for a small peri-anastomotic regionP Confluent endothelium on prosthetic grafts has been achieved, however, by seeding endothelial cells prior to implantation. This technique has been studied extensively during the past years, and has shown favourable results in animal models. 4' 5 Although some successful human experiments have been described, 5' 6 * Please address all correspondence to: H. J. M. Verhagen, University Hospital Utrecht, Department of Surgery (G.04.228), PO Box 85500, 3508 GA Utrecht. clinical introduction has lagged behind. One of the major problems of human endothelial cell seeding is the limited availability of HLA-compatible endothelial cells. 6 Mesothelial cells have been suggested as a possible alternative. Mesothelial cells can be harvested easily in large quantities from the omentum of the graft recipient 7-11 and, like endothelial cells, they have anti-coagulant, 12 anti-thrombotic, 13 and fibrinolytic 14 activity. Furthermore, mesothelial cells also grow in a monolayer and express contact inhibition. The aim of the present study was to test the hypothesis that MCseeding improves patency and decreases neointimal formation of small diameter ePTFE vascular grafts in a canine model.
Methods

Animal procedures
Animal experiments were approved by the ethics committee of the University of Utrecht. Animal care and 1078-5884/98/060489 + 06 $12.00/0 © 1998 W.B. Saunders Company Ltd. handling conformed to the "Position of the American Heart Association on Research Animal Use". Five conditioned adult Beagle dogs, weighing 10.8-12.8 kg, were used for graft implantation, and were housed in an animal laboratory with alternating light and dark cycles throughout the experiment. All surgical procedures were carried out under general anaesthesia. As premedication, a combination of methadone (10 rag), acepromazine (10 mg), and atropine (0.5 rag) were administered intravenously. Subsequently, anaesthesia was induced with thiopental (250 mg i.v.) and maintained by mechanical ventilation with a combination of oxygen and nitrous oxide (1:2) with 1% halothane. During anaesthesia, E.K.G., temperature, and exhaled percentage CO2 were monitored. Pain medication (buprenorfine 0.1 mg) 'was administered by subcutaneous injection for 3 days, postoperatively.
Isolation and culture of mesotheliaI cells
Under sterile conditions, about half of the omentum was excised through a minilaparotomy. A small piece was fixed in 4% buffered formaldehyde for histological examination, and the rest was placed immediately in Medium 199 containing penicillin (100 units/ml), streptomycin (100 gg/ml), and amphotericin B (4 gg/ ml) (Gibco Europe Ltd, Paisley, U.K.; M199). After achieving haemostasis, the wound was closed in two layers with absorbable sutures (vicryl 2-0), and the animal was allowed to recover. Isolation of mesothelial cells was done as described previously. 8 In brief, the pieces of omentum were washed with phosphate buffered saline (PBS), cut in four equal pieces, and transferred to pre-warmed PBS containing 0.05% trypsin-0.02% EDTA (Gibco). After 15 min incubation at 37 °C under gentle shaking, the detached mesothelial cells were pelleted by centrifugation at 1200 rpm for 10 min. The pelleted cells were resuspended in 48 ml of M199 containing 20% Foetal Calf Serum (Gibco; FCS), and cultured in four polystyrene flasks (Costar, Cambridge, MA, U.S.A.; 75 c m 2 each), which had been precoated with fibronectin. Cells were grown in a fully humidified 5% CO2 incubator at 37 °C. Culture medium was routinely changed every other day, and after about 5 days a confluent monolayer of mesothelial cells was formed. Their identity was confirmed by demonstrating the presence of intracellular cytokeratins using a monoclonal antibody (Dako, Glostrup, Denmark; MNF116; ~-C k ) , 9'~5 and by the absence of staining with a polyclonal antibody against human von Willebrand factor (Sigma, ~-VWF). 
Cell seeding
On the day before graft implantation (after 6 days of culture), the cells were rinsed with HEPES buffered saline (10 mM HEPES, 145 mM NaC1, pH 7.4; HBS) and harvested by trypsin treatment. The number of cells was determined by fluorometric measurement of the DNA content of aliquots from harvested cells, complexed with Hoechst dye (33258; Boehringer Mannheim; Germany). Cell numbers were derived from a standard curve relating quantities of DNA in MC suspensions with known quantities of a calf thymus DNA (Sigma) standard. 16' 17 All cells were resuspended in 12 ml of culture medium. Cell viability was determined by Trypan Blue dye exclusion and always exceeded 95%.
For seeding the complete luminal surface of the vascular prostheses, we used a seeding chamber as described before. 18 In brief, a standard ePTFE prosthesis (8 cm long, 4 mm I.D.; supplied by W.L. Gore & Assoc., Flagstaff, Arizona, U.S.A.) was immobilised between two stainless steel cannulas inside a polymethylpentene tube (Fig. 1 ). The total volume of the prosthesis and cannulas measured 3.0 ml, the cannulas could be moved within the seeding chamber and locked in place. With the prosthesis in situ, the seeding chamber was sterilised. Fibronectin was purified from Beagle plasma in the same way as described for purification of human fibronectin, 19 and was used to precoat the graft for I h at 37 °C (100 ~tg/ml = 15 ~tg/cm2). After rinsing the prosthesis with HBS, the first 3.0 ml of the seeding suspension were introduced and the prosthesis was placed horizontally in the incubator. After 30 min, the culture medium with the unattached cells were removed, and another 3.0ml was introduced. The prosthesis was placed again horizontally in an incubator, rotated at a 90 ° angle from its previous position. This seeding procedure was repeated twice, in which the vascular prosthesis was rotated completely (2 h), so that all sides were seeded with cells.
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Subsequently, the prosthesis was kept horizontally in the incubator overnight (,-~20 h) for implantation the next day.
Graft implantation
Each dog underwent bilateral replacement of a segment of the carotid artery with a seeded graft on one side and an unseeded control on the other. During induction of anaesthesia, a single dose of antibiotics was administered intravenously (amoxicillin 400 mg). Both carotid arteries were exposed through a midline neck incision, and 100 U/kg of heparin was given (Leo Pharmaceutical, Weesp, The Netherlands). A 2 cm segment of each of the carotid arteries was removed and to match the retraction of the cut ends, a 4 cm graft was implanted. First, the non-seeded ePTFE control graft was implanted on the right side. The autologous seeded graft was used in the left carotid artery. When the seeded graft was implanted, it was rinsed thoroughly with M199 culture medium (without serum), and two I cm pieces were excised and fixed for scanning electron microscopic (SEM) evaluation of the seeding process. Care was taken to keep the seeded prostheses misted during the operation. End-to-end anastomoses were made microscopically (magnification x 10), using 8-0 polypropylene interrupted sutures (prolene, Ethicon, Somerville, NJ, USA). Just prior to the last suture, the grafts were flushed to remove any possible clots. After achieving haemostasis, the wounds were closed in three layers using absorbable sutures (vicryl 2-0), and the animal was allowed to recover. All dogs were medicated throughout the experiments with oral acetyl salicylic acid (ASA, 80 mg once a day), beginning 1 week before implantation.
Assessment of graft patency
Patency of the implanted grafts was assessed in three different ways. First, by palpation just prior to closure of the wounds. Second, by magnetic resonance angiography (MRA), I week and 4 weeks after implantation. Third, at the time of sacrifice by incision of the distal native artery. MRA was performed at the National In Vivo NMR Facility, Utrecht University, The Netherlands, on a SISCO 200MHz (4.7T) spectrometer (Varian, Palo Alto, U.S.A.), equipped with an actively shielded gradient coil (maximal gradient strength 32mT/m and a 29.5cm clear bore). Imaging was performed using a saddle type transmit-receive radiofrequency coil (inner diameter 16 cm). The dogs were anaesthetised as described before, placed in a supine position in a cradle, and the target area was positioned in the centre of the radiofrequency coil. Routinely, a transversal multislice Tl-weighted spin-echo sequence was used as a scout to select the slices of interest. Multiple positions proximal-to, distal-to, and in the centre of the grafts were selected. These positions were then imaged with a flow sensitive SSFP sequence. The intensity of the occurring flow artifacts gives a good qualitative impression of flow present.
For the multislice Tl-weighted spin-echo sequence the following parameters were typically used: repetition time: 2.7 s; echo time 25 ms; 5 ms sinc pulses; field-of-view: 15 x 15 cm2; slice thickness: I mm; 128 x 128 points data matrix in the acquisition, zerofilled to 512 x 512 for display and evaluation. The SSFP sequence required the following parameters: repetition time: 100 ms; echo time 6 ms; 2 ms gauss pulses; fieldof-view: 15 x 15 cm2; slice thickness: I mm; 128 x 128 points data matrix in the acquisition, zero-filled to 512 x 512 for display and evaluation.
Removal of grafts
Immediately after the second MRA, 4 weeks after implantation of the grafts, the midline neck incision was reopened. Heparin (100 U/kg) was administered to prevent graft thrombosis during removal. The grafts were exposed by careful dissection. The carotid arteries were clamped distal to the prostheses and a small incision was made just proximal to the clamps as a final control of graft patency. Subsequently, clamps were placed proximal to the grafts as well and the dogs were sacrificed by intravenous administration of pentobarbital (3 gram). Each graft was removed together with an adjacent segment of the native artery at both ends, rinsed with PBS, and fixed for histological and scanning electron microscopic examination.
The abdominal cavity was inspected macroscopically, to see whether removal of half of the omenturn had any influence on intra-abdominal adhesion formation.
Histopathological examination
Representative transverse sections of approximately 0.3 cm from each of the seeded and control grafts were fixed in 4% buffered formaldehyde for at least 24 h, Eur J Vasc Endovasc Surg Vo115, June 1998 and embedded in paraffin. Serial sections of 5 gm thickness were cut (at intervals of 300 gm) and stained with either haematoxylin and eosin (HE), elastic van Gieson (EvG), or periodic acid silver methenamin/ azophloxin-anilin (PASM/AZAN), and with the antibodies ~-Ck, ~-VWF, and ~-SMA (smooth muscle actin; Sigma). For quantification of neointima (NI), HEstained sections were photographed at x 10 magnification. The specimens were then analysed morphometrically using a computerised image analysis system (Zeiss Video Plan; Zeiss; Germany). The thickness of the neointima was measured at four different spots within one section, five sections (at intervals of 300 gm) were measured. All measurements (n = 20) for one prosthesis were averaged.
Each graft prepared for scanning electron microscopy (SEM) was fixed in 2% glutaraldehyde for i h, postfixed in 1% osmium tetroxide (Sigma) for i h, and then dehydrated through increasing concentrations of ehtanol (50-100%). Samples were critical point dried (Balzers Union, Lichtenstein; CPD 010), sputtered with gold (Balzers Union, SCD 040), and finally examined with a scanning electron microscope (Camscan, Cambridge, U.K.). demonstrated that a confluent monolayer of mesothelial cells was present on the luminal surface of the grafts at the time of implantation (Fig. 2 ).
Statistical analysis
Results are expressed as mean+standard deviation (S.D.). A paired non-parametric test was used to determine significant differences (Wilcoxon signed rank test). A p value <0.05 was considered significant.
Results
Isolation of mesothelial cells
From every dog, about half of the omentum ( ~ 75 cm2; 15-20 g) was excised for cell isolation. No growth failures were found after cell isolation. At the time of sacrifice, no anatomical changes or adhesion formation was seen in the abdominal cavity. At the day of seeding (6 days after isolation) a mean of 9.5 x 106 (range: 7.7-11.6 x 10 6) mesothelial cells were harvested and resuspended in 12 ml of M199 containing 20% FCS. The mean cell density used for seeding the grafts was 3.3 x 105 cells/cm 2 (range: 2.7-4.0 x 105). Scanning electron microscopic evaluation of the seeding process
Patency of implanted grafts
Just prior to closing of the wound after graft implantation, all grafts were palpated and found to be open. One week after implantation, MRA was performed in four dogs and demonstrated that all eight grafts were patent. Two of the seeded grafts, however, showed decreased flow and reduction in lumen diameter on the level of the prosthesis. After 4 weeks, MRA was performed on all five dogs. The dog that was not available for MRA after 1 week showed a complete occlusion of the seeded prosthesis. One of the two seeded grafts that had shown a clear lumen reduction after 1 week was now occluded, the other one showed minimal flow. Two seeded prostheses, and all control grafts, were patent without angiographic lumen reduction. There had been no neurological symptoms despite occlusion or severe stenosis.
Histopathological examination
All grafts showed some degree of peripheral tissue ingrowth into the prosthetic material. On the luminal surface, hardly any tissue was found in the control grafts (Fig. 3a) . Two MC seeded grafts showed a complete occlusion, and three showed a thick neointima, which was present throughout the complete graft (Fig. 3b) . The thickness of the neointima is expressed in Table 1 . All the seeded grafts showed significantly more intimal tissue than the control grafts (p<0.01). Staining the seeded grafts with PASM/ AZAN, and with antibodies against SMA, vWF, and Ck demonstrated that the neointima consisted largely of myofibroblasts and connective tissue matrix. No autologous MC could be found. The occluded seeded grafts showed an almost completely organised thrombus. The presence of endothelial cells in the midportion of any of the grafts could not be demonstrated.
SEM of the luminal surface of the control grafts demonstrated a thin rough layer of fibrinous material on the ePTFE with erythrocytes, leucocytes, and platelets attached to it. Pannus ingrowth of an endotheliallike non-thrombogenic cellular layer covered all anastomoses and stopped at a distance of about 5 m m from each suture line inside the prostheses (Fig. 4 ). Anastomotic stenoses were not observed. SEM of the seeded grafts showed acellular fibrous tissue on the surface of the prostheses. All adjacent native carotid arteries showed a non-thrombogenic surface with intact endothelium.
Discussion
When prosthetic grafts are implanted into humans, the luminal surface becomes covered with platelets, blood cells and fibrin. R° In man, prosthetic grafts fail to develop an endothelial cell lining spontaneously, 3 so the surface remains thrombogenic for years and contributes to accelerated luminal occlusion. The creation of a biological, anti-thrombotic lining on the luminal surface of prosthetic grafts may be achieved by cell seeding prior to implantation. Endothelial cells (EC) are naturally best suited to line blood vessels, but it takes weeks to culture enough cells to line a complete peripheral bypass and growth failures occur in about 25% of the cases. 6 Veins large enough to isolate sufficient numbers of cells would obviously be the preferred choice of bypass conduit. 1 Mesothelial cells (MC) could be an alternative for EC since they have anti-coagulant, anti-thrombotic and fibrinolytic properties, 12-14 and it takes only about 5 days to culture enough cells. 7-1° This study was designed to investigate in vivo the possibility of using MC for cell seeding onto small diameter vascular prostheses.
By implanting both a seeded and a control graft in one dog, we could exclude the known variability in haemostatic properties between dogs. The dogs were medicated throughout the experiments with ASA because in small-calibre grafts in dogs, antiplatelet drugs are necessary to keep the control graft from clottingY 1 After 4 weeks, the seeded prostheses Pieces of ePTFE vascular prostheses (4 cm length, 4 mm internal diameter) were implanted end-to-end in the carotid position in four dogs.
A standard prosthesis was placed on the right side, a seeded prosthesis was placed in the left position. After i week, patency was assessed by magnetic resonance angiography (MRA) in four dogs. Four weeks after implantation, MRA was performed in all five dogs and the prostheses were removed for histological examination. Intimal thickness is stated as mean,, S.D., based on 20 measurements throughout the complete length of the explanted prostheses. The Wilcoxon signed-rank test was used for statistical analysis. occl: occluded. NLR: no angiographic reduction in lumen diameter. showed either occlusion, severe stenosis, or distinct lumen reduction, while the control grafts showed hardly any decrease in lumen diameter. The accelerated formation of neointimal tissue may therefore be explained by the MC seeding process. Human mesothelial cells in culture are known to increase the expression of tissue factor, the physiological activator of coagulation. 9 We have described before that manipulation of culture conditions decreased the tissue factor expression on MC to the same level as that measured on cultured adult endothelial cells, 8 and that the activity of anticoagulant thrombomodulin was significantly higher on MC than o n EC. 11 At present, no information is available on the haemostatic functions of canine MC. In our study, it is obvious that the procoagulant properties of mesothelial cells overpowered the anticoagulant properties. Whether this is due to the absence or low activity of thrombomodulin, prostacyclin, nitric oxide, or heparan sulphates on dog mesothelial cells is unknown. After 4 weeks, no MC could be demonstrated histologically on the seeded grafts. A possibility is that the cells were lost during thrombus formation, since high concentrations of thrombin and fibrin degradation products are present in bloodclots. Both are very strong cell activators, leading to dysfunction and detachment of seeded cells. 22' 23 Another possibility is that the MC were washed away from the surface of the prostheses, leaving the thrombogenic subcellular matrix. This may have happened after some time, because we have previously demonstrated that a monolayer of MC, present on the graft at the time of implantation, is resistant to shear stress characteristic for mediumsized arteries. 24 A third possibility is that the MC were still present but could not be recognised by the antibody, possibly because specific receptors on MC changed due to alteration of environment. From this study, no conclusions could be drawn on the time of onset of thrombus formation. We confirmed patency of all grafts by palpation after implantation, so acute occlusion due to massive activation of the coagulation cascade by tissue factor did not occur. On the other hand, histology of the seeded grafts showed organised tissue, suggesting that the thrombus formation occurred quite some time before sacrifice.
Patency of the carotid grafts was assessed noninvasively at 1 and 4 weeks after implantation by magnetic resonance angiography (MRA). This rapidly developing imaging technique has been applied to many regions of the body as and seems to be capable of providing anatomic information equivalent to contrast arteriography (CA). [26] [27] [28] In this study, occlusion or severe stenosis was imaged correctly by MRA, but the moderately stenosed seeded grafts could not be distinguished from the completely open controls. In the past we used Doppler recordings to monitor graft patency but that proved to be very unreliable when ePTFE grafts were used. Duplex ultrasonography is probably the best way to monitor graft patency noninvasively in this model.
Recently, a compilation of the results of nine published trials was described, all using 4 mm inner diameter synthetic grafts in a paired dog model of endothelial cell seeding, a° A positive benefit of EC seeding with respect to graft patency was consistently observed. Cell seeding studies using omentally derived cells were also described before, but it is difficult to make a comparison with these studies since there are justifiable doubts about the characterisation of the cells in those studies. Most of them described the use of microvascular endothelial cells isolated from the omentum, 29' 3° but EC are usually not isolated from the omentum. 31 This could mean that MC were used instead of EC, making it necessary to re-evaluate these studies before comparisons can be made. Well-characterised MC have been used for cell seeding procedures in animal models, but no significant change in thrombogenicity or patency was shown3 ~ Studying this work more closely, the results seem predictable. A low cell inoculum was used and the cells were inadequately attached and spread on the Dacron prostheses, resulting in an almost complete loss of cells, as was demonstrated after 48 h. Inadequately attached MC, however, are lost within minutes when they are subjected to physiological shear forces. 1s ' 24 From this study, we may conclude that the process of mesothelial cell seeding does not improve patency, nor does it decrease neointimal formation, of small diameter ePTFE grafts in Beagle dogs. Although many MC functions are still unknown, it seems that the procoagulant properties of cultured MC were more effective than the anticoagulant function. The prosthetic material proved to be thrombogenic, but ingrowth of a completely anti-thrombogenic endothelium was observed in all control grafts. This supports the original idea of endothelial cell seeding, and makes it worth studying other sources for cell seeding procedures which may provide anti-thrombogenic vascular prostheses.
